Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8 USD | -5,88% | +34,66% | +11,58% |
23/04 | VolitionRx Limited lanceert klinische tests in de VS en Europa via Antech | CI |
26/03 | Transcript : VolitionRx Limited, Q4 2023 Earnings Call, Mar 26, 2024 |
Omzet 2024 * | 3,63 mln. 3,39 mln. | Omzet 2025 * | 16,48 mln. 15,37 mln. | Marktkapitalisatie | 65,65 mln. 61,21 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -36 mln. -33,56 mln. | Nettowinst (verlies) 2025 * | -32 mln. -29,83 mln. | EV/omzet 2024 * | 15,6 x |
Nettoliquiditeiten 2024 * | 8,9 mln. 8,3 mln. | Nettoschuld 2025 * | 18,4 mln. 17,15 mln. | EV/omzet 2025 * | 5,1 x |
K/w-verhouding 2024 * |
-1,97
x | K/w-verhouding 2025 * |
-2,48
x | Werknemers | 110 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 76,08% |
Recentste transcriptie over VolitionRx Limited
1 dag | -5,88% | ||
1 week | +34,66% | ||
Lopende maand | +5,68% | ||
1 maand | +9,19% | ||
3 maanden | -27,27% | ||
6 maanden | -0,77% | ||
Lopend jaar | +11,58% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 06-10-11 |
Terig Hughes
DFI | Director of Finance/CFO | 54 | 01-02-21 |
Gaetan Michel
COO | Chief Operating Officer | 51 | 01-02-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 06-10-11 |
Martin Faulkes
CHM | Chairman | 80 | 06-10-11 |
Guy Innes
BRD | Director/Board Member | 67 | 06-10-11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 0,8 | -5,88% | 354 848 |
23-04-24 | 0,85 | +41,67% | 3 440 054 |
22-04-24 | 0,6 | -2,60% | 51 117 |
19-04-24 | 0,616 | -0,19% | 245 813 |
18-04-24 | 0,6172 | +3,89% | 255 788 |
uitgestelde koers Nyse, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,58% | 65,65 mln. | |
-14,52% | 11,48 mld. | |
+44,03% | 3,27 mld. | |
-33,09% | 2,2 mld. | |
-18,60% | 2,05 mld. | |
-27,59% | 1,49 mld. | |
+17,10% | 1,01 mld. | |
-3,06% | 743 mln. | |
-33,50% | 413 mln. | |
-46,94% | 377 mln. |